CHDI Foundation’s mission is to rapidly and collaboratively develop therapeutics that will slow the progression of Huntington’s disease. We contend that all clinical trials should be registered and their methodologies and results transparently published as quickly as is feasible. This information is the very least that research participants and the wider patient populations deserve from the scientific community and is essential in designing better, smarter and faster future trials that will deliver therapeutics as quickly as possible.
